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Abstract
Background: Low dietary intake of the essential nutrient choline and its metabolite betaine may
increase atherogenesis both through effects on homocysteine methylation pathways as well as
through choline's antioxidants properties. Nutrient values for many common foods for choline and
betaine have recently become available in the U.S. nutrient composition database. Our objective
was to assess the association of dietary intake of choline and betaine with incident coronary heart
disease (CHD), adjusting for dietary intake measurement error.
Methods: We conducted a prospective investigation of the relation between usual intake of
choline and betaine with the risk of CHD in 14,430 middle-aged men and women of the biethnic
Atherosclerosis Risk in Communities study. A semi-quantitative food frequency questionnaire was
used to assess nutrient intake. Proportional hazard regression models were used to calculate the
risk of incident CHD. A regression calibration method was used to adjust for measurement error.
Results: During an average 14 years of follow-up (1987–2002), 1,072 incident CHD events were
documented. Compared with the lowest quartile of intake, incident CHD risk was slightly and non-
significantly higher in the highest quartile of choline and choline plus betaine, HR = 1.22 (0.91, 1.64)
and HR = 1.14 (0.85, 1.53), controlling for age, sex, education, total energy intake, dietary intakes
of folate, methionine and vitamin B6. No association was found between dietary choline intake and
incident CHD when correcting for measurement error.
Conclusion: Higher intakes of choline and betaine were not protective for incident CHD. Similar
investigations in other populations are of interest.
Background
The essential nutrient choline, its metabolite betaine, as
well as folate and methionine are all metabolically inter-
related by transmethylation pathways [1-4]. Through
under-methylation of DNA, low dietary intakes of choline
and betaine alter the epigenetic regulation for a series of
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Like folate, choline is involved in the methylation of
homocysteine (a putative cardiovascular risk factor) to
methionine through a betaine-dependent pathway. When
folate availability diminishes there is an increased
demand for betaine as a methyl donor [7]. Conversely,
when choline availability is decreased the demand for
folate is increased [8]. Because of the interrelationship of
folate and choline pathways, both nutrients should be
considered in epidemiological studies assessing the rela-
tionship between dietary intake of these compounds and
cardiovascular disease.
Until recently analysis of choline intake was not possible
because the choline content of most foods had not been
measured accurately [9,10] and thus far only three obser-
vational studies have been published of dietary intake of
choline and betaine [11-13]. We investigated the hypoth-
esized association of a low dietary intake of choline and
betaine with incident coronary heart disease (CHD) in a
large middle-aged biracial cohort of men and women
sampled from four U.S. locales. We further investigated
whether the estimated risk of CHD varies by intake of
folate or methionine, by menopausal status, sex or race.
We contrasted the results with those obtained using a cal-
ibration method to adjust for known measurement error
in the assessment of four interrelated nutrients: choline,
folate, methionine and total energy intake.
Methods
The study was conducted in the cohort component of the
Atherosclerosis Risk in Communities (ARIC) Study, a pro-
spective observational biracial follow-up of 15,792 men
and women between the ages of 45 and 64, recruited from
Forsyth County, NC, Jackson, MS, suburbs of Minneapo-
lis, MN, and Washington County, MD [14]. Institutional
review board approval was obtained by each participating
field center and the coordinating center. Written informed
consent was obtained from each study participant. The
analyses excluded cohort members who had CHD at base-
line (n = 766), race other than white and African-Ameri-
can (n = 48), missing dietary information for either folate
or methionine (n = 8), and extreme reported caloric
intake values (below 500 kcal for women and 700 kcal for
men, and above 3,500 for women and 4,500 for men, cor-
responding to the 3rd and 97th percentiles of the data dis-
tribution; n = 540). Prevalent CHD was defined as
evidence of a prior myocardial infarction (MI) by electro-
cardiogram readings taken during the baseline clinic visit,
self-reported physician diagnosis of MI, or self-reported
cardiovascular surgery/coronary angioplasty. After apply-
ing these exclusions, 14,430 individuals remained for
analysis.
The ingested choline and betaine was quantified, during
the baseline visit (1987–1989), with a 66-item version of
the Willett semi-quantitative food frequency question-
naire, FFQ [15]. The participants were asked how often,
on average, they had consumed listed food items during
the previous year. Nine frequency responses were listed
ranging from more than six per day to almost never. We
calculated daily servings by converting the consumption
frequency to servings per day. Dietary choline and betaine
were estimated as the sum of daily intakes, using a choline
and betaine database composed with the U.S. Department
of Agriculture (USDA) choline and betaine content in
common foods database, database that contains 207 food
items [10].
Incident non-fatal MI and fatal CHD were ascertained,
validated and classified following the standardized ARIC
cohort and community surveillance protocol [16]. We
considered the intakes of choline, and choline plus
betaine, in multivariable models. We adjusted for total
energy intake as a continuous variable after evaluating
that adjustment using the residual method [17] produced
similar results. The following confounding variables were
also included in the models: age, sex, education, dietary
folate, methionine, B6 vitamin and cholesterol, race, dia-
betes, ARIC center, menopausal status (reported cessation
of menses), and a series of CHD risk factors such as smok-
ing, hypertension, body mass index (BMI) and family his-
tory of CHD. Using a likelihood ratio test we assessed the
effect measure modification of dietary folate intake, sex,
menopausal status, race, education, ARIC center and alco-
hol intake. Due to women's capacity to form the choline
moiety de novo the amount of choline necessary in the
daily diet is influenced by sex and menopausal status.
Alcohol intake, a known folate antagonist, may plausibly
increase the requirement for folate intake. Folate and alco-
hol were categorized with a cutoff point at the lowest and
the highest quartile, respectively. We calculated hazard
ratios (HR), per quartiles of dietary intake, using Cox pro-
portional hazard regression. Verification of the propor-
tional hazard assumptions was assessed using plots of the
log(-log) survival curves. We contrasted the results with
those obtained using the procedure described below to
correct for measurement error. Statistical analyses were
conducted using SAS software [18]. All p-values were two-
tailed.
We applied regression calibration [19-21] to correct for
measurement error in the following independent varia-
bles: choline (choline plus betaine), folate, methionine
and total energy intake. To enable this adjustment we
assessed the reliability of the dietary instrument in a ran-
dom sample of 1,004 subjects whose dietary intake was
measured three years after the ARIC baseline. From each
field center an equal number of participants were selected.Page 2 of 8
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ner as was done during the ARIC baseline examination.
The intraindividual variability was calculated and the cor-
relation between measures made at repeat visits, the relia-
bility coefficient, was estimated using mixed models
regression [22]. The reliability coefficients for the nutri-
ents of interest used for the adjustment procedure were
0.50 for choline (0.50 for choline plus betaine), 0.53 for
folate, 0.48 for methionine and 0.43 for caloric intake.
The general estimator for the measurement error model
was applied to the longitudinal analysis of dietary choline
with incident CHD. We used a bootstrapping technique to
estimate the variance of beta coefficients obtained in the
final longitudinal analysis corrected for measurement
error. We repeated the bootstrap sampling one thousand
times.
Results
Among the 14,430 participants in this study, the median
intake of choline was 302 mg/day in men, 271 mg/day in
women, 286 mg/day in whites and 274 mg/day in blacks.
For betaine the median intakes were 101 mg/day in men,
89 mg/day in women, 95 mg/day in whites and 91 mg/
day in blacks. The distribution of the main baseline char-
acteristics of the study population according to gender is
presented in Table 1. The correlations between the interre-
lated nutrients choline, folate and methionine were as fol-
lows: 0.35 for choline-folate, 0.45 for choline-methionine
and 0.55 for folate-methionine. In our population, the
top five contributors of choline intake were red meat –
side dish (11.4%), eggs (11.1%), red meat – main dish
(10.4%), low fat milk (8.3%) and chicken without skin
(8.3%). The top five contributors of betaine were dark
bread (24.9%), white bread (18.1%), spinach (10.4%),
cold breakfast cereals (8.2%) and pasta (4.7%). The top
ten food items (and the quantity per serving) on the FFQ
that contribute to the intake of these two micronutrients
in the ARIC population are presented in Table 2.
Over an average of 14 years of follow-up (1987–2002),
1072 validated incident CHD events occurred. Neither
higher intakes of dietary choline nor betaine were signifi-
cantly associated with incident CHD. Compared with the
lowest quartile of intake, incident CHD risk was 22%
higher [HR = 1.22 (0.91, 1.64)] and 14% higher [HR =
1.14 (0.85, 1.53)] in the highest quartile of choline and
choline plus betaine respectively, controlling for age, sex,
education, total energy intake, and dietary intakes of
folate, methionine and vitamin B6 (Table 3). Further
adjustment for race, diabetes status, ARIC field center and
dietary cholesterol, vitamins B12 and B2, as well as for
other CHD risk factors, such as obesity (defined as a body
mass index, BMI, higher than 30), hypertension, smoking
status and estimated family history of CHD, produced
similar risk estimates.
Because eggs, milk and green vegetables are important
contributors to choline and betaine intake, we performed
sensitivity-type analyses to further adjust for intake of sat-
urated fatty acids, animal fat, dietary fiber and animal pro-
tein. The hazard ratios across the quartiles of choline and
total choline intakes (considering the same lowest quar-
tile as referent, and adjusting for all confounders consid-
ered in models #2, Table 3, namely age, sex, education,
total energy intake, dietary intakes of folate, methionine,
vitamin B6, race, diabetes status, ARIC field center, meno-
pausal status and dietary cholesterol) remained practically
unchanged, suggesting that the higher risk associated with
the highest intake is not due to confounding from uncon-
trolled dietary factors (Table 3).
No effect measure modification was detected by sex, men-
opausal status, race, ARIC center, education or folate
intake analyzed as a continuous variable. Correction for
measurement error in the dietary intake of choline and
related nutrients, using models containing continuous
nutrient variables, provided similar results. For choline,
the hazard ratio for those in the highest quartile, com-
pared with those in the lowest, was 1.34 (0.98, 1.85).
When using the bootstrapping procedure and obtained
the 95% confidence interval for the corrected choline
regression coefficient, the risk estimate remained non-sig-
nificant.
To examine the effect of folate fortification that was man-
dated after January 1998 we conducted a supplemental
analysis with exclusion of events that occurred prior to
that date. For choline and for choline plus betaine the risk
estimates were weakened and still not significant. Specifi-
cally, compared with the lowest quartile, the hazard ratios
for choline were 0.80 (0.62, 1.04), 1.01 (0.76, 1.36) and
0.97 (0.64, 1.47) for the second, the third and the fourth
quartile of the dietary intake, respectively. For choline
plus betaine, the risks of incident CHD by quartiles were
0.86 (0.67, 1.11), 0.98 (0.73, 1.30) and 0.90 (0.61, 1.35),
respectively.
In order to use the repeated measurement of dietary intake
completed during visit 3 (1993–1995) in all ARIC partic-
ipants, we did an additional analysis in which we investi-
gated the risk of incident CHD among participants which
did not develop this outcome before this visit. For both
choline and for choline plus betaine the risk estimates
remained similar. Specifically, compared with the lowest
quartile, the hazard ratios for choline were 1.05 (0.81,
1.37), 0.94 (0.70, 1.30) and 1.09 (0.74, 1.59) for the sec-
ond, the third and the fourth quartile of the dietary intake,
respectively. For choline plus betaine, the risks of incident
CHD by quartiles were 1.23 (0.94, 1.61), 1.22 (0.89,
1.66) and 1.50 (1.00, 2.26), respectively. We adjusted for
all the variables included in the models #3 (table 3).Page 3 of 8
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Over 14 years of follow-up of this large prospective bira-
cial cohort of men and women we did not find a signifi-
cant association between dietary intake of choline (or
choline plus betaine) and the risk of incident CHD,
whether or not correction for measurement error was
applied. Statistical control for the potential effect of die-
tary folate, dietary methionine and other covariates did
not substantially influence the risk estimates for either
choline or choline and betaine. Further, we found no evi-
Table 1: Distribution of baseline characteristics of the ARIC Study population (N = 14,430) according to gender.
Characteristic Gender
Men Women
Age, y* 54.4 (5.76) 53.7 (5.71)
African American, % 23.0 29.9†
Diabetes, % 8.6 9.6
Current smoker, % 27.5 24.6†
Body mass index, kg/m2* 27.4 (4.15) 27.8 (6.10)
Choline intake, mg/day* 332.1 (124.7) 294.2 (111.9)
Betaine intake, mg/day* 118.1 (55.4) 102.4 (47.1)
Alcohol intake, g/day* 10.16 (17.83) 2.90 (7.21)
Dietary cholesterol, mg/day* 278.2 (139.4) 230.2 (112.0)
Dietary methionine, g/day* 1.74 (0.66) 1.63 (0.66)
Dietary fiber, g/day* 17.3 (7.94) 16.9 (8.02)
Dietary folate, μg/day* 234.4 (102.4) 221.5 (100.2)
Dietary saturated fatty acid, g/day* 24.2 (10.6) 19.9 (9.2)
* Numbers presented are mean (SD).
† p < 0.001 for chi-square test comparing the two genders.
Table 2: Top ten food items on the FFQ that contribute to the intake of choline and betaine among 14,430 participants in the ARIC 
Study.
Choline
Ranking Food group % of nutrient Quantity per serving (mg)
1 Read meat – side dish 11.4 163.5
2 Eggs 11.1 110.4
3 Red meat – main dish 10.4 130.1
4 Low fat milk 8.3 40.7
5 Chicken without skin 8.3 111.6
6 Chicken or turkey (with skin) 4.0 92.8
7 Coffee 3.5 6.2
8 Fish (cod, perch, catfish) 3.3 94.8
9 Potatoes, mashed or baked 3.3 32.9
10 Whole milk 2.6 34.6
Betaine
Ranking Food group % of nutrient Quantity per serving (mg)
1 Dark bread 24.9 34.4
2 White bread 18.1 25.5
3 Spinach 10.4 72.9
4 Cold breakfast cereals 8.2 21.6
5 Pasta 4.7 34.9
6 Cookies 3.6 11.9
7 Coffee 3.1 1.9
8 Hamburgers 2.5 13.8
9 Biscuits or cornbread 2.4 10.9
10 Donut 2.2 25.3Page 4 of 8
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quartiles of dietary intakes of choline.
Choline, an essential nutrient for humans [23], is found
in several compounds that are methyl-donors. Supple-
mentation in the dietary intake range of betaine, a methyl-
donor continuously produced from choline [24], leads to
immediate and long term lowering of plasma homo-
cysteine [25], a putative CHD risk factor [26]. Homo-
cysteine, a sulfur aminoacid whose metabolism has a
direct cytotoxicity effect on vascular endothelium [27],
stands at the intersection of two pathways [28]. One cata-
lyzes the synthesis of the amino acid cysteine and the
other remethylation to form methionine, a process that
requires folate and vitamin B12. In an alternative reaction,
betaine, the oxidative by-product of choline, serves as a
donor of methyl groups to homocysteine to form methio-
nine [29]. Thus, the two metabolic pathways provide
alternate mechanisms for removal of homocysteine as
shown in Figure 1. The increase in blood homocysteine
after a methionine load [3] and consequent vascular cyto-
toxicity, or the aberrant methylation produced by a low
plasma choline and plasma betaine with possible
increased atherogenesis [5,6], provide the putative mech-
anisms that could explain an increase in CHD risk. Alter-
natively, the intrinsec antioxidant properties of choline
[30] could decrease the endothelial dysfunction and the
risk for occlusive vascular events in those with a relatively
higher intake of this nutrient.
Whereas there is research suggestive of an inverse associa-
tion between dietary folate and incident CHD [31], the
extant literature on dietary choline is small [11-13]; the
current study is the first to explore choline as well as
betaine in relationship with cardiovascular outcomes in a
biracial cohort of both men and women. No relationship
was also found recently between dietary intake of choline
and betaine and cardiovascular events in a cohort of post-
menopausal women enrolled in the Dutch EPIC cohort
[13]. Until recently it was not possible to calculate dietary
choline intake in humans and there are no nationally rep-
resentative estimates of this intake from food [23] because
the choline content of foods had not been included in
major nutrient databases. Food choline data were unreli-
able due to older, imprecise assay procedures. As a conse-
quence an estimated Average Requirement (EAR) for
choline remains to be established. The proposed adequate
intake (AI) for choline was set at 550 mg/day for men and
425 mg/day for women [32]. It is unknown whether
intakes of choline in the U.S. meet the AI. In the ARIC
cohort, the median and 75th percentiles of choline intake
were 284 and 367 mg/day, respectively (unpublished
results). Only 6% of men and 11% of women had an
intake of choline above that proposed as the AI for this
population. Choline intake was associated with sex, race
and menopausal status.
Repeat measurement mixed modeling permits the estima-
tion of measurement reliability, which in turn permits
adjustment for measurement error such as through a
regression calibration [19-21]. One approach is to replace
the observed values of the variables measured with error
(in our case, the nutrients of interest) with multivariate
Stein estimates of the true values, conditional on the val-
ues of the variables measured without error and the
observed values of the variables measured with error [33].
Because the risk estimates relating nutrient intake to CHD
were very close to the null, little change in the hazard ratio
was observed when measurement error correction was
applied.
An explanation for the slightly increased CHD risk toward
the higher end of choline intake distribution, opposite to
what we initially expected, could be that choline is
required for normal secretion of very low density lipopro-
tein from liver; perhaps provision of choline mobilizes
Table 3: Hazard rate ratios (and 95% CI) for CHD across quartiles of dietary intakes among 14,430 participants in the ARIC Study.
Quartile (Q) of dietary intake
Q1 Q2 Q3 Q4
(N = 3607) (N = 3608) (N = 3608) (N = 3607)
Choline <217 mg/d 217–283 mg/d 283–363 mg/d >363 mg/d
Model #1* Referent 0.89 (0.73, 1.08) 1.11 (0.90, 1.38) 1.22 (0.91, 1.64)
Model #2† Referent 0.84 (0.69, 1.03) 1.03 (0.82, 1.29) 1.05 (0.76, 1.45)
Model #3‡ Referent 0.93 (0.76, 1.13) 1.10 (0.87, 1.37) 1.09 (0.79, 1.50)
Total choline <298 mg/d 298–384 mg/d 384–486 mg/d >486 mg/d
Model #1 Referent 0.91 (0.75, 1.10) 1.07 (0.86, 1.33) 1.14 (0.85, 1.53)
Model #2 Referent 0.87 (0.72, 1.05) 1.01 (0.81, 1.26) 0.99 (0.73, 1.35)
Model #3‡ Referent 0.86 (0.67, 1.11) 1.21 (0.97, 1.52) 1.14 (0.83, 1.56)
*In models #1, adjustment was made for age, sex, education, total energy intake, and dietary folate, methionine and vitamin B6.
†In models #2, adjustment was made for all of the above plus race, diabetes status, ARIC field center, menopausal status and dietary cholesterol.
‡In models #3, adjustment was made for all of the variables listed in models #2 plus dietary intake of saturated fatty acids, animal fat, dietary fiber 
and animal protein.Page 5 of 8
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mitting deposition in atheromas [33]. A higher intake of
choline and betaine, which increases the methylation
potential of methionine, may result in a change of the cell
phenotype that also promotes the development of athero-
sclerotic plaque [35].
There are several limitations of the present study. First is
that the food frequency questionnaire used in ARIC tends
to underestimate the absolute dietary intake for a particu-
lar nutrient, as is commonly the case for semi-quantitative
dietary assessment tools [15]. Nevertheless, the FFQ used
in this study was designed to rank participants and it is
likely that we properly discriminated individuals in the
highest and lowest categories of intake which was the
focus of our analyses. The foods with the highest content
in choline – eggs, milk, liver, red meat, poultry and fish,
as well as the foods with the highest content in betaine –
spinach, white bread and breakfast cereals, were items
included in the ARIC FFQ. One can overcome the limita-
tions of a dietary tool through the use of a biomarker.
However, there is no reliable blood biomarker for dietary
intake of choline. As it is known from clinical settings,
plasma concentrations of choline and betaine decrease
when subjects are fed a low choline diet, but the amount
of decrease is not highly correlated with susceptibility to
develop organ dysfunction while on this diet [36].
Another limitation of our investigation is the absence of
supplemental B vitamin information including folate,
which was queried only during subsequent examinations
of the ARIC cohort.
Despite these limitations, there are a series of advantages
for this study. The analyses are based on an extended fol-
low-up of one of the largest biracial populations of U.S.
adults, with the added strengths of validated CHD out-
comes and a standardized collection of covariate informa-
tion. These are elements that support the internal validity
of the findings. Because in ARIC the dietary assessment
was conducted before the mandatory supplementation of
some foods (such as flour) with folate in the late 1990s,
the study was able to minimize the interference with those
compounds in its ascertainment of the exposure.
Conclusion
Our study is the first to investigate the relationship
between dietary intake of choline and choline plus
betaine and the risk of incident coronary hearth disease in
a large biethnic prospective cohort with participants of
both genders. It represents an early investigation of two
Metabolism of homocysteine and the remethylationto methionine by the alternative folate and betaine pathwaysFigure 1
Metabolism of homocysteine and the remethylationto methionine by the alternative folate and betaine path-
ways. THF: tetrahydrofolate; MTHFR: methylentetrahydrofolate reductase; BHMT: betaine-homocysteine methyltransferase; 
MTR: methionine synthase reductase. Note: in boxes – choline, betaine, folate and methionine concentrations in plasma
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composition database. We found that choline and choline
plus betaine intakes were not predictors of incident CHD
in the ARIC cohort. A higher choline intake did not prove
protective for incident CHD among those with a low
folate intake. Our findings offer information toward an
understanding of the complex etiology of coronary occlu-
sive events in relation to methyl-donor compounds. This
study invites similar investigations in other populations
and of other atherosclerotic events.
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